-
-
-
-
-
-
-
MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation
-
-
-
-
-
-
-
MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development
-
-
-
-
-
-
-
MiNK Therapeutics, Inc. (INKT) Misses Q1 EPS by 64c
-
-
-
-
-
-
-
MiNK Therapeutics to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report
-
-
-
-
-
-
-
MiNK Reports First Quarter 2024 Results
-
-
-
-
-
-
-
MiNK to Provide Third Quarter 2023 Financial Report and Corporate Update
-
-
-
-
-
-
-
MiNK Therapeutics, Inc. (INKT) Tops Q4 EPS by 44c
-
1,219,113 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

